C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61K 51/04 (2006.01) A61P 25/00 (2006.01) C07D 217/20 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2592353
Certain tetrahydroisoquinoline compounds are histamine H3 receptor and serotonin transporter modulators useful in the treatment of histamine H3 receptor-and serotonin-mediated diseases.
Certains composés de tetrahydroisoquinoline sont un récepteur d'histamine H3 et des modulateurs du transporteur de sérotonine utiles dans le traitement de maladies à médiation du récepteur d'histamine H3 et à médiation de sérotonine.
Carruthers Nicholas I.
Gomez Leslie A.
Jablonowski Jill A.
Keith John M.
Letavic Michael A.
Janssen Pharmaceutica N.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Tetrahydroisoquinoline compounds for treatment of cns disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroisoquinoline compounds for treatment of cns disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroisoquinoline compounds for treatment of cns disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1796754